YCBDMICRO

cbdMD, Inc.

HealthcareDrug Manufacturers - Specialty & Generic
$0.70
$0.00(-1.12%)
52W$0.47
$2.56
Updated Jun 29, 02:00 AM
RSI47
RS Rating11/99
Beta0.75
Volatility153%
F-Score6/9
Mkt Cap$7M
WEAKENING

Price Action

5Y Daily
50 DMA150 DMA200 DMA

Technical Summary

WEAKENING

cbdMD, Inc. is in a technical downtrend, trading below key resistance levels with a broken trend structure. Relative strength is weak (RS Rating: 11), showing significant lag compared to the market leaders. Earnings growth of 56% provides fundamental context to the price action. Investors should exercise caution due to high volatility (153% annualized), which requires wider risk management.

Relative Strength
11
out of 99
Lagging
Trend Score
1/4
Minervini Criteria
WEAKENING
Risk (Beta)
0.75
vs S&P 500
DEFENSIVE
52W Position
11%
from 52W low
Near Low
Trend & Momentum Analysis

Trend Template (Minervini)

WEAKENING1/4 Criteria Met
CriterionValueStatus
Price > 50 SMA$0.78
50 SMA > 100 SMA$0.78
100 SMA > 150 SMA$0.85
150 SMA > 200 SMA$0.87

Price vs Moving Averages

PeriodValueSpreadSignal
20 SMA$0.71-1.93%BELOW
50 SMA$0.78-11.28%BELOW
100 SMA$0.78-11.18%BELOW
150 SMA$0.85-18.30%BELOW
200 SMA$0.87-20.23%BELOW

Price Performance

1D-1.1%
1W+0.7%
1M-6.2%
3M-8.2%
6M-58.6%
YTD-40.1%
1Y-20.5%
3Y-61.6%
52-Week Trading Range11% from low
$0.70
52W Low$0.47
52W High$2.56

Technical Indicators

RSI (14)NEUTRAL
46.7
305070
Setup ScoreCOOL
5/10
Base depth: 92.1%

Risk Profile

Beta
0.75
52W Vol
153%
ATR
$0.04
Max DD (1Y)
-71%

Volume Analysis

Today
50D Avg
1.54M
Vol Ratio
0.00x
Liquidity
ILLIQUID

Earnings Momentum

Q3'25-40%
$-0.21
Q4'25+72%
$-0.08
Q1'26+84%
$-0.04
Q2'26+56%
$-0.08
Fundamentals & Growth

Growth Trends

Compounded Sales Growth

10 Years:
5 Years:-14.45%
3 Years:-18.46%
TTM:+2.00%

Compounded Profit Growth

10 Years:
5 Years:
3 Years:
TTM:+51.04%

Stock Price CAGR

10 Years:-54.90%
5 Years:-77.00%
3 Years:-61.65%
1 Year:-20.47%

Return on Equity

10Y Avg:-67.2%
5Y Avg:-71.0%
3Y Avg:-75.0%
Last Year:-33.6%

Key Metrics

Market Cap$7M
Gross Margin62.4%
Net Margin-10.6%
Piotroski F-Score6/9

Frequently Asked Questions

Is YCBD in an uptrend right now?

YCBD has a trend score of 1/4 based on Minervini's Stage Analysis. Currently showing broken structure - 1 of 4 trend criteria are met.

Is YCBD overbought or oversold?

YCBD's RSI (14) is 47. The stock is in neutral territory, neither overbought nor oversold.

Is YCBD outperforming the market?

YCBD has a Relative Strength (RS) Rating of 11 out of 99. YCBD is currently lagging the broader market.

Where is YCBD in its 52-week range?

YCBD is trading at $0.70, which is 27% of its 52-week high ($2.56) and 11% above its 52-week low ($0.47).

How volatile is YCBD?

YCBD has a Beta of 0.75 and 52-week volatility of 153%. It's less volatile than the S&P 500 - generally more stable.

Disclaimer: Data is for informational purposes only. May be delayed or contain errors. Past performance does not guarantee future results. This is not financial advice. Always conduct your own research and consult professionals before making investment decisions.